Percutaneous thermal ablation of primary and secondary lung tumors: Comparison between microwave and radiofrequency ablation.


Journal

Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 16 05 2019
revised: 22 07 2019
accepted: 24 07 2019
pubmed: 14 8 2019
medline: 20 5 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

The purpose of this study was to retrospectively compare microwave (MWA) and radiofrequency (RFA) ablation in the percutaneous treatment of primary and secondary lung tumors. A total of 115 patients with a total of 160 lung tumors (primary, n=41; secondary, n=119) were retrospectively included. There were 56 men and 59 women with a mean age of 67.8±12.7 (SD) years (range: 42-89 years) who underwent either MWA (61 patients; 79 tumors) or RFA (54 patients; 81 tumors). The primary study endpoints were local recurrence during follow-up and the incidence of complications during and following thermal ablation. The MWA and RFA groups were compared in terms of treatment efficacy and complication rates. Demographics were similar in the two groups. Mean tumor diameter was smaller in RFA group (13.1±5.1 [SD] mm; range: 4-27mm) than in MWA group (17.1±8.3 [SD] mm; range: 5-36mm) (P<0.001). Ablation volumes at one month were 24.1±21.7 (SD) cm MWA favorably compares with RFA and can be considered as an effective and safe thermal ablation technique for lung tumors, especially in situations where RFA has limited efficacy.

Identifiants

pubmed: 31402333
pii: S2211-5684(19)30174-3
doi: 10.1016/j.diii.2019.07.008
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-791

Informations de copyright

Copyright © 2019 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

V Aufranc (V)

Department of Medical Imaging, CHU Montpellier-Lapeyronie, 371 Avenue du Doyen Gaston-Giraud, 34295 Montpellier cedex 5, France. Electronic address: vincent.aufranc@gmail.com.

G Farouil (G)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

M Abdel-Rehim (M)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

P Smadja (P)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

M Tardieu (M)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

S Aptel (S)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

A Guibal (A)

Department of Medical Imaging, Hôpital Saint-Jean, 66000 Perpignan, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH